HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renke Maas Selected Research

dimethylarginine

1/2016Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies.
12/2011Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase.
8/2009Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort.
1/2008Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.
3/2007Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
12/2005Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
8/2002The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Renke Maas Research Topics

Disease

20Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 02/2002
9Chronic Kidney Failure (Chronic Renal Failure)
07/2011 - 02/2002
8Hypertension (High Blood Pressure)
12/2009 - 11/2003
7Atherosclerosis
03/2014 - 02/2002
6Drug-Related Side Effects and Adverse Reactions
03/2022 - 11/2003
5Essential Hypertension
10/2007 - 08/2005
4Chronic Renal Insufficiency
01/2020 - 11/2012
4Stroke (Strokes)
10/2016 - 03/2009
4Coronary Disease (Coronary Heart Disease)
03/2013 - 07/2005
4Inflammation (Inflammations)
01/2013 - 02/2002
4Hypercholesterolemia
02/2008 - 02/2004
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 11/2007
3Proteinuria
01/2020 - 07/2005
3Myocardial Infarction
02/2012 - 04/2008
3Pre-Eclampsia (Preeclampsia)
01/2010 - 02/2004
3Coronary Artery Disease (Coronary Atherosclerosis)
04/2008 - 12/2005
3Diabetes Mellitus
09/2006 - 02/2004
2Cognitive Dysfunction
01/2017 - 09/2009
2Ischemic Stroke
02/2012 - 02/2010
2Insulin Resistance
11/2007 - 09/2006
2Erectile Dysfunction
12/2005 - 08/2002
2Syncope (Fainting)
08/2004 - 05/2002
1Liver Diseases (Liver Disease)
03/2022
1Neoplasms (Cancer)
01/2021
1Wounds and Injuries (Trauma)
01/2020
1Dementia (Dementias)
01/2020
1Hemorrhage
12/2016
1Pain (Aches)
12/2016
1Torsades de Pointes (Torsade de Pointes)
01/2016
1Atrial Fibrillation
01/2016
1Pulmonary Arterial Hypertension
10/2012
1Critical Illness (Critically Ill)
12/2009
1Cerebrovascular Trauma
09/2009
1Systemic Scleroderma (Systemic Sclerosis)
05/2009
1Intermittent Claudication
03/2009
1Angina Pectoris
03/2009
1Transient Ischemic Attack
03/2009
1Heart Failure
03/2009
1Vascular Diseases (Vascular Disease)
04/2008
1Alzheimer Disease (Alzheimer's Disease)
01/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
08/2007
1Infections
03/2007
1Hyperlipidemias (Hyperlipidemia)
09/2006

Drug/Important Bio-Agent (IBA)

28N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2021 - 02/2002
19Nitric Oxide Synthase (NO Synthase)IBA
01/2021 - 02/2002
13Arginine (L-Arginine)FDA Link
01/2020 - 02/2004
9Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2019 - 02/2002
7dimethylarginineIBA
01/2016 - 08/2002
6Biomarkers (Surrogate Marker)IBA
10/2012 - 05/2009
5Telmisartan (Micardis)FDA Link
10/2007 - 07/2005
4Pharmaceutical PreparationsIBA
03/2022 - 09/2013
4EnzymesIBA
03/2014 - 02/2008
4dimethylargininaseIBA
03/2014 - 02/2008
4C-Reactive ProteinIBA
01/2013 - 02/2002
4NisoldipineFDA Link
10/2007 - 09/2006
4Antihypertensive Agents (Antihypertensives)IBA
04/2007 - 11/2003
3HomoarginineIBA
01/2020 - 01/2013
3symmetric dimethylarginineIBA
03/2013 - 02/2010
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
10/2007 - 09/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2016 - 04/2008
2Apolipoproteins E (ApoE)IBA
03/2014 - 05/2010
2Serum AlbuminIBA
01/2013 - 02/2004
2Angiotensin Receptor AntagonistsIBA
04/2007 - 07/2005
28-epi-prostaglandin F2alphaIBA
07/2005 - 02/2004
1AlbuminsIBA
03/2022
1Sodium-Glucose Transport ProteinsIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2021
1trimethyloxamine (trimethylamine N-oxide)IBA
01/2020
1NitratesIBA
11/2017
1Cholinergic Antagonists (Anticholinergics)IBA
01/2017
1Acetaminophen (Paracetamol)FDA LinkGeneric
12/2016
1Ibuprofen (Motrin)FDA LinkGeneric
12/2016
1F2-Isoprostanes (F2 Isoprostanes)IBA
10/2012
1Peroxidase (Myeloperoxidase)IBA
12/2011
1ApolipoproteinsIBA
05/2010
1OxidesIBA
08/2009
1Clopidogrel (Plavix)FDA Link
04/2008
1Purinergic P2 Receptors (ADP Receptor)IBA
04/2008
1Purinergic P2Y Receptor AntagonistsIBA
04/2008
1Cyclooxygenase InhibitorsIBA
04/2008
1IsotopesIBA
02/2008
1Angiotensin IIIBA
02/2008
1Adenosine Triphosphate (ATP)IBA
11/2007
1CreatinineIBA
08/2007
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
07/2007
13-nitrotyrosineIBA
03/2007
1ProcalcitoninIBA
03/2007
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2007
1Adenosine (Adenocard)FDA LinkGeneric
03/2007
1Nitroglycerin (Dynamite)FDA LinkGeneric
03/2007
1Interleukin-6 (Interleukin 6)IBA
03/2007
1Insulin (Novolin)FDA Link
09/2006
1AdiponectinIBA
09/2006

Therapy/Procedure

5Therapeutics
01/2021 - 05/2002
4Medication Errors (Medication Error)
08/2017 - 03/2013
1Drug Prescriptions
03/2022
1Contraindications
03/2022
1Home Nursing (Nursing, Home)
01/2020
1Patient Readmission
02/2012